The MHRA inspected CMC Biologics’ manufacturing and testing facilities in Bothell, WA in late March 2012.
CMC Biologics chief operations officer Gustavo Mahler said, "This achievement demonstrates the viability of our manufacturing, process, and quality systems, which is the foundation for our customers’ clinical and commercial success."
CMC Biologics expanded its stainless steel biopharmaceutical manufacturing facility, which added production capacity to accommodate additional cGMP manufacture of biopharmaceuticals.